US 10918657
Treatment of spinal cord injury or traumatic brain injury by inhibition of synuclein protein aggregation
granted A61KA61K31/194A61K31/255
Quick answer
US patent 10918657 (Treatment of spinal cord injury or traumatic brain injury by inhibition of synuclein protein aggregation) held by The Board of Regents of the University of Texas System expires Mon Feb 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Feb 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/194, A61K31/255, A61K31/6615, A61K31/663